C12N 2710/24151
Methods of production or purification of viral material
C12N2710/24151 (Methods of production or purification of viral material) appears on 85 US grants and 125 published applications in this corpus.
Search patents in C12N- Granted patents
- 85
- Published applications
- 125
- Assignees
- 55
- Inventors
- 201
- Latest grant
- 20 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 1 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 2 |
| 2005 | 0 | 3 |
| 2006 | 1 | 1 |
| 2007 | 0 | 1 |
| 2008 | 2 | 3 |
| 2009 | 0 | 7 |
| 2010 | 2 | 9 |
| 2011 | 11 | 12 |
| 2012 | 6 | 12 |
| 2013 | 11 | 9 |
| 2014 | 7 | 4 |
| 2015 | 7 | 3 |
| 2016 | 4 | 8 |
| 2017 | 5 | 6 |
| 2018 | 5 | 7 |
| 2019 | 3 | 6 |
| 2020 | 8 | 5 |
| 2021 | 2 | 3 |
| 2022 | 2 | 4 |
| 2023 | 0 | 3 |
| 2024 | 2 | 5 |
| 2025 | 4 | 4 |
| 2026 | 2 | 8 |
By publication year. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Synthetic chimeric vaccinia virus20 Jan 2026US 12,529,036 B2Tonix Pharma Limited
- Methods and systems for manufacturing viral vectors6 Jan 2026US 12,516,349 B2Regeneron Pharmaceuticals, Inc.
- Method for producing a virus and a harvesting solution composition2 Dec 2025US 12,486,487 B2Hangzhou Converd Co., Ltd.
- Methods for improved poxvirus yields26 Aug 2025US 12,398,375 B2Arizona Board of Regents on behalf of Arizona State University
- Oncolytic virus expressing a car T cell target and uses thereof22 Jul 2025US 12,364,724 B2City of Hope
- Tumor neoantigen vaccine system specifically marking heterologous protein, and use thereof8 Oct 2026US 2026/0306620 A1China Pharmaceutical University
- Rapid selection system for the generation of recombinant enveloped viruses8 Oct 2026US 2026/0308627 A1Probiogen AG
- Methods of Isolating Poxviruses from Avian Cell Cultures27 Aug 2026US 2026/0248906 A1Bavarian Nordic A/S
- Multi-antigen chimeric vaccine against poxvirus and use thereof20 Aug 2026US 2026/0240989 A1Institute of Microbiology, Chinese Academy of Sciences
- Compositions and Methods for Enhancement of mRNA Vaccine Performance and Vaccination against Mpox18 Jun 2026US 2026/0166138 A1Yale University
Most cited
By later US patents
- Modified Vaccinia Ankara virus variant and cultivation method30US 7,445,924 B2Bavarian Nordic A/S · 2008
- Recombinant vaccinia viral vectors20US 6,372,455 B1Arizona Board of Regents · 2002
- Purification of vaccinia viruses using hydrophobic interaction chromatography20US 8,003,364 B2Bavarian Nordic A/S · 2011
- Modified Vaccinia Virus Ankara for the vaccination of neonates20US 8,163,293 B2Bavarian Nordic A/S · 2012
- Modified vaccinia ankara virus variant and cultivation method18US 7,964,395 B2Bavarian Nordic A/S · 2011